|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.59 USD | +4.03% |
|
+18.59% | +46.88% |
| 06-09 | Cartesian Therapeutics Signs Licensing Agreement With WestGene to Develop Therapies for Autoimmune Diseases | MT |
| 05-26 | Cartesian Therapeutics, Inc. Announces Executive Changes | CI |
| Market Cap | 311M 272M 250M 233M 442M 29.63B 449M 3B 1.17B 14.56B 1.17B 1.14B 50.18B | P/E 2026 * |
-2.55x | P/E 2027 * | -2.77x |
|---|---|---|---|---|---|
| Enterprise Value | 168M 147M 135M 126M 238M 15.96B 242M 1.62B 629M 7.85B 629M 616M 27.04B | EV / Sales 2026 * |
304x | EV / Sales 2027 * | 22.5x |
| Free-Float |
46.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cartesian Therapeutics, Inc.
| 1 day | +4.03% | ||
| 1 week | +18.59% | ||
| Current month | +1.63% | ||
| 1 month | +65.21% | ||
| 3 months | +69.17% | ||
| 6 months | +56.66% | ||
| Current year | +46.88% |
| 1 week | 9.14 |  | 10.95 |
| 1 month | 5.77 | | 11 |
| Current year | 5.6 | | 11 |
| 1 year | 5.6 | | 15.57 |
| 3 years | 5.6 | | 42.6 |
| 5 years | 5.6 | | 42.6 |
| 10 years | 5.6 | | 42.6 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-02 | Fiscal year | 758,001 | 2.8594% | |||
| 04-02 | Fiscal year | 22,740 | - | |||
| 04-02 | Fiscal year | 22,740 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.03% | +18.59% | -6.86% | - | 311M | |
| +0.68% | +5.00% | +78.89% | +135.72% | 58.73B | |
| +2.32% | +5.89% | +76.81% | +99.20% | 53.92B | |
| -10.61% | +8.38% | -9.90% | -9.62% | 24.67B | |
| -0.30% | +6.82% | +13.60% | +428.91% | 24.19B | |
| +4.74% | +13.47% | +46.43% | +0.03% | 18.8B | |
| -0.29% | +9.58% | +44.35% | -28.08% | 17.61B | |
| 0.00% | +16.74% | +171.12% | +355.99% | 16.25B | |
| +3.50% | +4.92% | +26.07% | +192.26% | 14.04B | |
| +6.72% | +20.94% | +51.67% | - | 13.9B | |
| Average | +2.86% | +8.51% | +49.22% | +146.80% | 24.24B | |
| Weighted average by Cap. | +2.20% | +6.01% | +59.30% | +137.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 552K 483K 444K 414K 784K 52.58M 796K 5.33M 2.07M 25.85M 2.07M 2.03M 89.07M | 402K 351K 323K 301K 570K 38.23M 579K 3.87M 1.51M 18.79M 1.51M 1.47M 64.75M |
| Net income | -122M -107M -98.3M -91.62M -174M -11.65B -176M -1.18B -459M -5.73B -459M -449M -19.73B | -131M -114M -105M -97.89M -186M -12.45B -188M -1.26B -490M -6.12B -491M -480M -21.08B |
| Net Debt | -144M -125M -115M -107M -204M -13.66B -207M -1.38B -538M -6.72B -539M -527M -23.14B | -302M -264M -243M -226M -429M -28.76B -436M -2.91B -1.13B -14.14B -1.13B -1.11B -48.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | $10.59 | +4.03% | 178,033 |
| 01/07/26 | $10.18 | -2.30% | 168,488 |
| 30/06/26 | $10.42 | +8.09% | 535,370 |
| 29/06/26 | $9.640 | +2.34% | 191,870 |
| 26/06/26 | $9.420 | +5.49% | 765,474 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RNAC Stock
Select your edition
All financial news and data tailored to specific country editions
